untitled design

Britain: Confidence in coronavirus vaccines on the rise, concerns about side effects removed

Trust in vaccines COVID-19 is on the rise, with people willing to be vaccinated to grow as concerns about side effects go away, according to research conducted in 14 countries and Britain, the results of which were made public today, reports APE.

This research by the Institute of Global Health Innovation (IGHI) of Imperial College London and the polling company YouGov showed that confidence in vaccines against COVID-19 increased in 9 of the 14 countries surveyed, including France, Japan and Singapore, where confidence levels were previously low.

In the case of Britain, this recent survey, conducted from 8 to 21 February, showed that people in the UK are most willing to be vaccinated, with 77% saying they would get the COVID-19 vaccine if had one for him that week.

That figure rose to 55% in November, shortly before the first COVID-19 vaccine, Pfizer / BioNTech, was approved by the UK regulator for use in the UK.

At the same time people in France, Singapore and Japan remained among the least willing to get a COVID-19 vaccine at 40%, 48% and 48% respectively, but all three countries saw their confidence rise. vaccination against the disease caused by the new coronavirus since November, when only 25%, 36% and 39% respectively of their citizens were positive about its vaccination.

This research also shows that concerns about side effects vaccines have been removed in most countries, with less than half (45%) of all those surveyed now reporting concern.

Again people were most concerned about side effects France, τη Singapore and Japan, with about 6 in 10 feeling worried (56%, 59%, 61% respectively), while the British were the ones worried the least.

The most recent survey was conducted on more than 13,500 people in Australia, Canada, Denmark, France, Germany, Israel, Italy, Japan, the Netherlands, Norway, Singapore, South Korea and Spain. , Sweden and Britain.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular